Finding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work
Potential Sciences, a UK government-backed startup, is using AI models trained on computer-generated biochemical data to accelerate drug discovery. The approach aims to bypass traditional lab work, potentially speeding up the development of new drugs. The article highlights the startup's bet on synthetic data to overcome the laborious nature of pharmaceutical R&D.
AI Brief
The article covers a concrete AI application in drug discovery with a novel data strategy, offering timely insight into industry innovation.
Potential Sciences, a startup backed by the UK government, is betting that training AI models on computer-generated biochemical data can speed up the plodding process of developing new drugs.
Comments & Questions (0)
No comments yet
Be the first to comment!